Skip to main content
DeutschDE
European Commission logo print header

Genetics of Sepsis in Europe

Ziel

GenOSept is a specific targeted research project (STREP) which uses a multidisciplinary fundamental genomics approach (gene expression, structural genomics, population genetics) to examine genetic predisposition to sepsis. Sepsis (life-threatening infection) is a major public health problem throughout Europe. In the USA in 1995 it cost $17 billion to treat 751,000 patients with severe sepsis, of whom 28.6% died. The Center for Disease Control suggests that sepsis-attributable mortality rates are rising. We hypothesize that susceptibility to expensive new treatments, and fatal outcomes from severe sepsis, are in part, genetically determined. GenOSept work packages will test this hypothesis using the following approach. We will use gene expression studies to define novel candidate genes including those controlling programmed cell death. The novel candidate genes so identified will then be analysed in subsequent epidemiologic studies of genetic predisposition to sepsis-related mortality and morbidity in European intensive care units. The European Society of Intensive Care Medicine (ESICM) will co-ordinate a consortium of leading experts in sepsis, genomics, genetic epidemiology, biometrics and genetic high-throughput genotyping to link this new science to patient-centred outcomes. GenOSept will provide important data on gender-related mortality and morbidity. It will have a major impact on diagnosis and treatment of European sepsis patients in subsequent therapeutic trials by targeting risk subpopulations and focussing expensive new treatments. GenOSept will standardise protocols for genotyping, facilitate application of new knowledge in functional and structural genomics, harmonize high-throughput genotyping and quality control between major European centres, and contribute to reducing sepsis-related mortality in European health care.

Wissenschaftliches Gebiet

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

FP6-2003-LIFESCIHEALTH-I
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

STREP - Specific Targeted Research Project

Koordinator

EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
EU-Beitrag
Keine Daten
Adresse
Avenue Joseph Wybran 40
BRUSSELS
Belgien

Auf der Karte ansehen
Links
Gesamtkosten
Keine Daten

Beteiligte (13)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 26 März 2013

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/512155/de

European Union, 2024